Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lapuleucel-T MeSH Supplementary Concept Data 2025


MeSH Supplementary
Lapuleucel-T
Unique ID
C522647
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C522647
Registry Numbers
0
Heading Mapped to
*Cancer Vaccines
Frequency
2
Note
Autologous active cellular immunotherapy with lapuleucel-T was feasible, safe, and well tolerated. The treatment stimulated significant immune responses, which were enhanced after boost infusions
Source
J Clin Oncol 2007 Aug 20;25(24):3680-7
Date of Entry
2007/09/11
Revision Date
2007/09/11
Lapuleucel-T Preferred
page delivered in 0.002s